Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B9O

Crystal structure of Retinoic Acid Receptor alpha (RXRA) in complexed with S169 inhibitor

Summary for 7B9O
Entry DOI10.2210/pdb7b9o/pdb
DescriptorRetinoic acid receptor RXR-alpha, Nuclear receptor coactivator 2, 3-(5-(3,5-bis(trifluoromethyl)phenyl)-4-phenyloxazol-2-yl)propanoic acid, ... (4 entities in total)
Functional Keywordscomplex, structural genomics, structural genomics consortium, sgc, dna binding protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight27990.34
Authors
Ni, X.,Chaikuad, A.,Schierle, S.,Merk, D.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2020-12-14, release date: 2021-02-10, Last modification date: 2024-01-31)
Primary citationSchierle, S.,Chaikuad, A.,Lillich, F.F.,Ni, X.,Woltersdorf, S.,Schallmayer, E.,Renelt, B.,Ronchetti, R.,Knapp, S.,Proschak, E.,Merk, D.
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics.
J.Med.Chem., 64:5123-5136, 2021
Cited by
PubMed Abstract: The retinoid X receptors (RXR) are ligand-activated transcription factors involved in multiple regulatory networks as universal heterodimer partners for nuclear receptors. Despite their high therapeutic potential in many pathologies, targeting of RXR has only been exploited in cancer treatment as the currently available RXR agonists suffer from exceptional lipophilicity, poor pharmacokinetics (PK), and adverse effects. Aiming to overcome the limitations and to provide improved RXR ligands, we developed a new potent RXR ligand chemotype based on the nonsteroidal anti-inflammatory drug oxaprozin. Systematic structure-activity relationship analysis enabled structural optimization toward low nanomolar potency similar to the well-established rexinoids. Cocrystal structures of the most active derivatives demonstrated orthosteric binding, and profiling revealed superior PK properties compared to current RXR agonists. The optimized compounds were highly selective for RXR activation and induced RXR-regulated gene expression in native cellular and settings suggesting them as excellent chemical tools to further explore the therapeutic potential of RXR.
PubMed: 33793232
DOI: 10.1021/acs.jmedchem.1c00235
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.05 Å)
Structure validation

240971

数据于2025-08-27公开中

PDB statisticsPDBj update infoContact PDBjnumon